| Helvepharm AG - Lenalidomid Zentiva 15 mg, Hartkapseln | | 67850 | | 05 | | Lenalidomid Zentiva 15 mg | | Hartkapseln | | L04AX04 | | Lenalidomide | | 29.10.2020 | | |
| | Composition | | lenalidomidum 15 mg, cellulosum microcristallinum, lactosum 199.3 mg, carmellosum natricum conexum corresp. natrium 0.539 mg, magnesii stearas, Kapselhülle: gelatina, titanii dioxidum, E 132, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Lenalidomidum | 15 mg |
| | BAG: Active Agent | Dose |
|---|
| Lenalidomidum | 15 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | | | | | Drucktinte | | | 199.3 mg | | | | | | | | | | | Propylenglycol | | | | Titanium Dioxide | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 21 | 782.79 | 867.75 | A | SL | No |
|
|
